HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ultra-long-acting removable drug delivery system for HIV treatment and prevention.

Abstract
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently in clinical trials cannot be removed after administration even if adverse events occur. Here we show an ultra-LA removable system that delivers drug for up to 9 months and can be safely removed to stop drug delivery. We use two pre-clinical models for HIV transmission and treatment, non-human primates (NHP) and humanized BLT (bone marrow/liver/thymus) mice and show a single dose of subcutaneously administered ultra-LA dolutegravir effectively delivers the drug in both models and show suppression of viremia and protection from multiple high-dose vaginal HIV challenges in BLT mice. This approach represents a potentially effective strategy for the ultra-LA drug delivery with multiple possible therapeutic applications.
AuthorsMartina Kovarova, S Rahima Benhabbour, Ivana Massud, Rae Ann Spagnuolo, Brianna Skinner, Caroline E Baker, Craig Sykes, Katie R Mollan, Angela D M Kashuba, J Gerardo García-Lerma, Russell J Mumper, J Victor Garcia
JournalNature communications (Nat Commun) Vol. 9 Issue 1 Pg. 4156 (10 08 2018) ISSN: 2041-1723 [Electronic] England
PMID30297889 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir
Topics
  • Animals
  • Anti-HIV Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Disease Models, Animal
  • Drug Delivery Systems (methods)
  • HIV Infections (drug therapy, prevention & control, virology)
  • HIV-1 (drug effects, genetics, physiology)
  • Heterocyclic Compounds, 3-Ring (administration & dosage, pharmacokinetics, therapeutic use)
  • Humans
  • Macaca mulatta
  • Mice, Inbred NOD
  • Mice, Knockout
  • Mice, SCID
  • Oxazines
  • Piperazines
  • Pyridones
  • Time Factors
  • Tissue Distribution
  • Virus Replication (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: